US Corporate Distress Financial Stress SEC Filings — June 25, 2026

25-06-2026

LakeShore Biopharma Co., Ltd. completed its merger with a parent company on June 24, 2026, becoming a wholly owned subsidiary. Shareholders approved the transaction on June 19, 2026, and ordinary shareholders receive $0.066 per share cash consideration. As a result, all reporting persons ceased to be beneficial owners of more than 5% of the company's shares, and the company's securities will be delisted from OTC Pink, with trading symbols to be removed.

• · The merger was approved by shareholders at an extraordinary general meeting on June 19, 2026.
• · The Plan of Merger was filed with the Cayman Islands Registrar of Companies and became effective on June 24, 2026.
• · Excluded shares and dissenting shares were cancelled without any payment.
• · 2020 Plan options and RSUs that were unvested became fully vested at the closing and were cancelled for cash consideration equal to the excess of $0.066 per share over the exercise price (for options) or $0.066 per share (for RSUs).
• · 2024 Plan options and RSUs were assumed by the Parent under a new equity incentive plan, with terms adjusted by an exchange ratio based on the per share consideration and fair market value of parent shares.
• · The company intends to file a Form 15 to suspend its SEC reporting obligations.
• · No transactions in ordinary shares were effected by reporting persons during the past 60 days.

25-06-2026

MoonLake Immunotherapeutics entered into an underwriting agreement to sell 9,000,000 ordinary shares and pre-funded warrants for up to 1,000,000 ordinary shares in a public offering, with expected gross proceeds of $200 million. The offering also grants underwriters a 30-day option for an additional 1,500,000 shares. There are no prior period comparisons in this filing, and no negative or flat performance metrics are disclosed.

• · The offering is conducted under a shelf registration statement (File No. 333-274286) effective September 11, 2023.
• · Pre-funded warrants have an exercise price of $0.0001 per share and are immediately exercisable.
• · Underwriters have a 30-day option to purchase up to an additional 1,500,000 ordinary shares at the public offering price less underwriting discounts.
• · Closing is expected on June 25, 2026, subject to customary conditions.
• · The company agreed to indemnify underwriters against certain liabilities including under the Securities Act of 1933.

25-06-2026

WidePoint Corp filed an 8-K on June 25, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 9.01 (Financial Statements and Exhibits). The filing indicates the company entered into a material definitive agreement, but no specific financial terms, counterparty, or strategic details were disclosed in the summary. The filing is mandatory for material agreements, but the lack of quantitative data limits assessment of financial impact or market reaction.

• · Filing date: June 25, 2026
• · AccNo: 0001654954-26-006193
• · File size: 695 KB
• · Sector: not specified
• · No financial statements or exhibits were detailed in the summary

25-06-2026

Grayscale Solana Staking ETF (GSOL) announced a significant reduction in its Sponsor's Fee from 0.35% to 0.19% per annum and a reduction in the Sponsor's Staking Fee from 23% to 7% of gross staking consideration, effective June 25, 2026. These fee cuts are intended to make the ETF more competitive and attractive to investors, though the filing does not disclose any corresponding changes in assets under management or performance metrics.

• · The Trust Agreement was originally dated September 19, 2025, and has been amended three times (Amendments No. 1, 2, and 3).
• · The Trust intends to file a prospectus supplement reflecting the reduced fees.
• · The filing is an 8-K covering Items 1.01, 8.01, and 9.01.

25-06-2026

Unusual Machines, Inc. (UMAC) announced the signing of a lease for a 14,000-square-foot manufacturing facility in Orlando, Florida, to support its battery operations ahead of the planned acquisition of Upgrade Energy, expected to close by mid-third quarter of 2026. The new facility will complement Upgrade Energy's existing 18,500-square-foot California operations and expand domestic battery production capacity. The company highlights the critical role of battery systems in drones and aims to strengthen its position as a Tier-1 NDAA-compliant drone component supplier.

• · The acquisition of Upgrade Energy is expected to close by mid-third quarter of 2026.
• · Upgrade Energy currently operates from an approximately 18,500-square-foot facility in California.
• · The global drone accessories market is currently valued at $17.5 billion and projected to reach $115 billion by 2032.
• · Unusual Machines' brand portfolio includes Fat Shark, the leader in FPV ultra-low latency video goggles.

25-06-2026

FS Credit Real Estate Income Trust, Inc. amended its Master Repurchase and Securities Contract Agreement with Capital One, National Association, increasing the Maximum Facility Amount to $750,000,000 and extending the Availability Period Expiration Date to November 19, 2027, with options for further extensions. The amendment also removed the previously defined 'Upsize Option' and reserved a prior provision. No financial performance data or period-over-period comparisons are included in this filing.

• · The amendment was executed on June 22, 2026, and filed on June 25, 2026.
• · The Availability Period Expiration Date was extended from a prior date to November 19, 2027, with Seller options for up to three additional one-year extensions (one automatic, two subject to Buyer approval).
• · The 'Upsize Option' defined term was removed entirely from the agreement.
• · Article 3(n) of the Repurchase Agreement was amended to be reserved.
• · Seller represented compliance with all terms and no continuing Default or Event of Default as of the amendment effective date.

25-06-2026

Western Midstream Operating, LP completed a public offering of $700,000,000 in 5.700% Senior Notes due 2036, priced at 99.705% of face value, with the net proceeds used to repay borrowings under its revolving credit facility and commercial paper program (including financing for the Brazos Delaware II, LLC acquisition) and for general partnership purposes. The notes mature on July 1, 2036, and are senior unsecured obligations of the Partnership. No subsidiary guarantees are initially provided, though future guarantees may be triggered under the revolving credit facility.

• · The notes are senior unsecured and rank equally with all existing and future senior indebtedness.
• · The indenture includes covenants limiting liens on principal properties, sale/leaseback transactions, mergers, and asset sales.
• · Interest is payable semi-annually on January 1 and July 1, beginning January 1, 2027.
• · Events of default include a 30-day grace period for interest payment default and a 60-day grace period for other covenant breaches.
• · The offering was made under shelf registration statement Form S-3 (File No. 333-296931-01), effective June 22, 2026.
• · Underwriters have engaged in prior commercial and investment banking transactions with the partnership and may continue to do so.

25-06-2026

Affirm Holdings, Inc. amended its revolving credit agreement on June 18, 2026, increasing aggregate commitments from $330M to $675M and extending maturity to June 18, 2029. The company also appointed Ryan Schneider, former CEO of Anywhere Real Estate, to its Board of Directors effective July 1, 2026. No amounts were outstanding under the credit agreement at closing, and borrowings will be used for general corporate purposes.

• · The amended credit agreement matures on June 18, 2029, but may accelerate if 2026 notes outstanding exceed $150M or the company's liquidity level within 91 days of their maturity.
• · Borrowings under the amended agreement are unsecured.
• · The credit agreement includes financial maintenance covenants requiring a maximum leverage ratio and minimum tangible net worth tested quarterly.
• · Ryan Schneider will serve on the Audit Committee and Nominating and Governance Committee.
• · No amounts were outstanding under the credit agreement at closing.

25-06-2026

Alico, Inc. entered into an Agricultural Lease Agreement with U.S. Sugar for approximately 3,280 acres in Hendry County, Florida, with an initial term from July 1, 2026 to June 30, 2027, and an option to extend for ten years. U.S. Sugar also has an option to purchase the property for $29,520,000 if exercised by June 30, 2029, or by June 30, 2031 if the lease is extended. The agreement includes customary provisions and provides potential future revenue from lease payments and possible sale.

• · Lease initial term: July 1, 2026 to June 30, 2027
• · U.S. Sugar has option to extend lease for additional ten-year term
• · Purchase option period ends June 30, 2029 (or June 30, 2031 if lease extended)
• · Purchase price based on $9,000 per acre, subject to annual increase and per acre adjustments
• · Property located in Hendry County, Florida

25-06-2026

Ingredion Incorporated entered into a Delayed Draw Term Loan Agreement on June 24, 2026, with JPMorgan Chase Bank, N.A. as Administrative Agent and several co-syndication agents and joint bookrunners. The facility is intended to finance the Rubicon acquisition, as referenced by the 'Rubicon Acquisition Documents' and 'Target Refinancing' covenants. The agreement includes customary representations, affirmative and negative covenants (including a maximum leverage ratio and minimum interest coverage ratio), and events of default.

• · The agreement includes a 'Certain Funds Period' during which conditions for borrowing are modified.
• · Covenants include a Maximum Leverage Ratio and Minimum Interest Coverage Ratio (specific ratios not disclosed in the excerpt).
• · The facility is governed by New York law and includes a waiver of jury trial.
• · The agreement references 'Outbound Investment Rules' compliance and anti-corruption/sanctions representations.

25-06-2026

Western Midstream Operating, LP (a subsidiary of WES) completed a public offering of $700,000,000 aggregate principal amount of 5.700% Senior Notes due 2036 on June 25, 2026. The net proceeds will be used to repay borrowings under its revolving credit facility and commercial paper program (including borrowings related to the acquisition of Brazos Delaware II, LLC) and for general partnership purposes and capital expenditures. The notes are senior unsecured obligations, rank equally with existing and future senior debt, and are governed by an indenture with customary covenants and events of default.

• · Interest on the Notes accrues from June 25, 2026, payable semi-annually on January 1 and July 1, with the first payment due January 1, 2027.
• · The Notes mature on July 1, 2036, unless redeemed earlier.
• · The Notes rank equally with all existing and future senior indebtedness and senior to any subordinated indebtedness of WES Operating.
• · Initially, no subsidiary guarantees the Notes; subsidiaries that become borrowers or guarantors under the revolving credit facility will jointly and severally guarantee the Notes in the future.
• · Underwriters include TD Securities, Barclays, Citigroup, and MUFG; the underwriting syndicate has engaged in prior commercial/investment banking transactions with WES Operating.
• · The offering was made under a shelf registration statement (File No. 333-296931-01) that became effective June 22, 2026.

25-06-2026

Liberty Energy Inc. entered into a $332.6 million equipment supply contract with Wärtsilä North America for power generation equipment for data center and distributed power projects. Delivery is expected from 2029 through 2030, with a parent guarantee provided. The contract includes limited liability for Wärtsilä and liquidated damages for missed milestones.

• · The contract price excludes import taxes, duties, tariffs, and similar charges payable by the purchaser.
• · Payment schedule includes a down payment at signing and installments tied to scheduling, delivery, and takeover.
• · Either party may terminate for material breach or continuing force majeure, subject to refunds, termination payments, or damages.
• · The full contract will be filed as an exhibit to the Q2 2026 10-Q.

25-06-2026

Mid-America Apartments, L.P. entered into a $350 million unsecured delayed draw term loan facility on June 22, 2026, with a syndicate of banks led by KeyBank. The facility matures on November 15, 2030, and proceeds will be used for general corporate purposes, including debt repayment. The loan includes an accordion feature allowing an increase to $550 million and carries variable interest rates based on SOFR plus a margin tied to credit ratings.

• · The loan agreement includes a cross-default provision triggered by default on other indebtedness exceeding $150 million.
• · A change of control of MAA or MAALP would constitute an event of default.
• · The facility is available for draws until December 21, 2026 (Commitment Expiration).
• · Amounts borrowed cannot be reborrowed after repayment.
• · The loan agreement contains financial covenants identical to those in MAALP's existing unsecured revolving credit facility.

25-06-2026

Palmer Square Capital BDC Inc. (PSBD) reduced the aggregate commitments under its credit facility from $525 million to $350 million, effective July 1, 2026. The reduction is intended to lower unused capacity and associated commitment fees, while maintaining sufficient capacity for future portfolio growth. No other terms of the facility were changed.

• · The reduction was made under a written notice (Commitment Reduction Notice) as permitted by the credit facility agreement.
• · The SPV pays commitment fees on the unused capacity, and reducing commitments lowers these fees.
• · The company views this as a tool to balance unused capacity for portfolio growth with cost reduction.

25-06-2026

Global Interactive Technologies, Inc. (GITS) received a Nasdaq notice on June 24, 2026 confirming it has regained compliance with Listing Rule 5250(c)(1) following the filing of its delinquent Form 10-Q on June 22, 2026. The company had previously been notified of non-compliance for failing to timely file its Form 10-K (filed May 26, 2026) and Form 10-Q. The delisting risk has been resolved.

• · The company received the initial delinquency notice for the Form 10-K on April 16, 2026.
• · The Form 10-K was filed on May 26, 2026.
• · The Form 10-Q was filed on June 22, 2026.
• · The Nasdaq compliance notice was received on June 24, 2026.

25-06-2026

New Fortress Energy Inc. (NFE) subsidiary NFE Brazil Financing Limited issued $973.5 million in 12.000% Senior Secured Notes due 2029, secured by Brazilian assets including power plant and port infrastructure. The notes carry a high 12% coupon, reflecting significant credit risk, and are governed by a comprehensive indenture with extensive covenants and collateral arrangements.

• · Issuer is NFE Brazil Financing Limited, a private limited company incorporated in England and Wales (registered number 15966083).
• · The indenture includes guarantors from time to time party thereto.
• · Collateral includes Brazilian assets via fiduciary sale agreements for CELBA I shares, NFE Power Brasil shares, and related assignments.
• · Notes are offered under Rule 144A (144A Global Note).
• · Commitment Letter dated May 11, 2026, with Specified Holders for the Initial Notes.
• · Trustee and Notes Collateral Agent is Wilmington Savings Fund Society, FSB.
• · Account Bank must be rated at least A- by S&P or A3 by Moody's.
• · The indenture contains standard covenants including limitations on restricted payments, additional indebtedness, dispositions, affiliate transactions, and liens.
• · Change of control triggers a redemption offer requirement.
• · Governing law is not explicitly stated in the excerpt but includes waiver of jury trial.
• · The notes are senior secured, ranking ahead of unsecured obligations.
• · No period-over-period comparisons are available in this filing.

25-06-2026

DSS, Inc. entered into a securities purchase agreement with related party Alset, Inc. for a $1,000,000 loan in exchange for a convertible promissory note and warrants to purchase 17,777,776 shares of common stock. The transaction is subject to stockholder approval and involves multiple overlapping directors and common control by Chairman Chan Heng Fai, raising governance concerns.

• · Conversion price of the note is $0.45 per share.
• · Warrant exercise price is $0.50 per share.
• · Warrants expire on the third anniversary of issuance.
• · Note matures five years from issuance date.
• · Transaction requires stockholder approval.
• · Interested directors recused themselves from board and audit committee deliberations.

25-06-2026

Beyond Meat entered into two warrant agreements with distributor Big Geyser on June 22, 2026, granting warrants to purchase up to 4,166,667 shares of common stock (0.8% of outstanding shares) in connection with a distribution agreement signed April 15, 2026. Tranche 1 allows purchase of 2,500,000 shares at $0.60 per share (18-month term), while Tranche 2 allows purchase of 1,666,667 shares at $0.001 per share (expiring 20 business days after the distribution agreement ends). The warrants were issued in a private placement exempt from registration under Section 4(a)(2) of the Securities Act.

• · The Distribution Agreement was entered into on April 15, 2026, prior to the warrant agreements on June 22, 2026.
• · Tranche 1 warrant is exercisable for 18 months from issuance; Tranche 2 warrant expires 20 business days after the Distribution Agreement ends.
• · Tranche 2 warrant allows net-share settlement in addition to cash exercise.
• · Warrants may not be transferred or assigned except to Permitted Transferees without company consent.
• · The warrants include weighted average anti-dilution adjustments for certain below-market issuances.

25-06-2026

Agilent Technologies closed a $600M private placement of 4.900% Senior Notes due 2032, issued at 99.968% of par. The notes are senior unsecured obligations, not guaranteed by subsidiaries, and include a change of control repurchase feature at 101%. The company also entered into a registration rights agreement with a potential 0.50% interest rate step-up if exchange offer is not completed by June 25, 2027.

• · Notes mature on January 15, 2032, with semi-annual interest payments starting January 15, 2027.
• · Notes redeemable at any time prior to December 15, 2031 at Treasury Rate plus 10 basis points, or at par thereafter.
• · Indenture contains covenants limiting liens, sale-leaseback, and mergers, with customary events of default.
• · Registration rights agreement requires exchange offer to be consummated by June 25, 2027, or shelf registration filed.
• · Additional interest of 0.25% per 90-day period up to 0.50% per annum for registration defaults.

25-06-2026

Taysha Gene Therapies announced a proposed underwritten public offering of $200.0 million shares of common stock and pre-funded warrants, with an additional 30-day option for underwriters to purchase up to 15% more shares. The offering is led by Jefferies, Goldman Sachs & Co. LLC, Piper Sandler, and Cantor, with Baird as lead manager. The company is a clinical-stage biotech focused on AAV-based gene therapies for CNS diseases, with lead program TSHA-102 for Rett syndrome.

• · The offering is subject to market conditions with no assurance of completion or final terms.
• · A shelf registration statement was filed with the SEC on November 4, 2025, and became automatically effective.
• · The company is clinical-stage with no approved products; TSHA-102 targets Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies.
• · Forward-looking statements highlight risks including uncertainties related to market conditions and completion of the offering.

25-06-2026

Floor & Decor Outlets of America, Inc. (the 'Borrower') entered into a $200,000,000 term loan credit agreement on June 24, 2026, with Goldman Sachs Bank USA as administrative and collateral agent, along with joint lead arrangers including BofA Securities, JPMorgan Chase, and Truist Securities. The proceeds are used to refinance existing term loans and pay related fees and expenses. The agreement includes extensive covenants, representations, and conditions typical for a secured credit facility, with no financial performance metrics disclosed in this filing.

• · The credit agreement is dated June 24, 2026, and filed on June 25, 2026.
• · Goldman Sachs Bank USA serves as both Administrative Agent and Collateral Agent.
• · BofA Securities, JPMorgan Chase Bank, and Truist Securities are joint lead arrangers and joint bookrunners.
• · The agreement includes provisions for incremental facilities, permitted debt exchanges, extension of term loans, and specified refinancing facilities.
• · The facility is secured by collateral and subject to an ABL/Term Loan Intercreditor Agreement with Bank of America, N.A. as ABL Agent.
• · The Borrower is a Delaware corporation (Floor and Decor Outlets of America, Inc.) and Holdings is FDO Acquisition Corp.
• · The agreement references the USA PATRIOT Act and includes anti-terrorism, anti-corruption, and sanctions representations.

25-06-2026

Upexi, Inc. entered into a three-year Advisory Services Agreement with Hivemind Capital Partners, LLC on June 22, 2026, for advisory and consulting services on business, operations, and capital markets strategies. The Advisor will receive quarterly fees in common stock equal to 125 basis points (1.25%) of market capitalization annually, subject to a 9.99% beneficial ownership cap. The agreement can be terminated for cause, with the Advisor entitled to the remainder of fees if terminated for the Company's uncured material breach.

• · Advisor has no authority to bind the Company or execute transactions on its behalf.
• · The agreement may be renewed for successive one-year periods upon mutual written agreement.
• · Fees in excess of the 9.99% beneficial ownership cap are payable in cash.
• · In the event of a cash takeout transaction, the Company must pay the Advisor a cash payment in lieu of further share issuances, calculated based on remaining term fees.
• · The Advisory Fee Shares are issued under Section 4(a)(2) and Rule 506(b) of Regulation D exemption from registration.
• · The Advisor represented itself as a 'qualified purchaser' or 'qualified institutional buyer'.

25-06-2026

Devon Energy completed the settlement of exchange offers for outstanding Coterra Energy notes, issuing $2.946 billion aggregate principal amount of new Devon notes across five series (2027-2055 maturities) in exchange for $2.946 billion of tendered Coterra notes plus cash. The transaction retired and canceled $2.946 billion of Existing Coterra Notes, leaving $303.6 million aggregate principal amount outstanding following settlement. The new notes are unsecured obligations ranking equally with Devon's other unsecured debt, and Devon entered into a registration rights agreement with dealer managers to file an exchange offer registration statement within 450 days.

• · The Exchange Offers were made pursuant to an offering memorandum dated May 22, 2026, as amended by a press release on June 8, 2026.
• · The New Devon Notes are governed by a Base Indenture dated August 28, 2024, as supplemented by the Third Supplemental Indenture dated June 25, 2026.
• · The New Devon Notes are general unsecured obligations ranking equally with all of Devon's other unsecured and unsubordinated debt.
• · Interest rates on New Devon Notes range from 3.90% (2027 notes) to 5.90% (2055 notes).
• · Maturity dates range from May 15, 2027 (2027 notes) to February 15, 2055 (2055 notes).
• · The Registration Rights Agreement requires Devon to use commercially reasonable efforts to file and cause to become effective a registration statement for an exchange offer within 450 days of settlement, failing which additional interest of up to 1.0% per annum may accrue.

25-06-2026

On June 23, 2026, Aytu BioPharma and Lannett Company mutually terminated their exclusive license agreement for Metadate CD, originally signed in May 2022. Aytu may continue to sell existing inventory and will pay royalties until sales cease. The product's net revenue for the quarter ended March 31, 2026 was only $49,000, indicating it was not a material revenue driver.

• · The Metadate Agreement was originally signed on May 11, 2022, and amended on July 6, 2023, and July 17, 2025.
• · The termination is effective as of June 23, 2026.
• · Aytu may continue to sell and distribute existing inventory at its sole discretion and must continue to provide royalty reports and pay royalties until sales cease.
• · The Termination Agreement will be filed as an exhibit to Aytu's Annual Report on Form 10-K for the year ended June 30, 2026.

25-06-2026

Nuvve Holding Corp. filed a Certificate of Designation for up to 150,000 shares of Series B Convertible Preferred Stock, each with a $1,000 stated value and a conversion price of $1.25 per share. The new series ranks senior to common stock and junior to existing Series A Preferred Stock, and carries no voting rights except as required by law. Issuance of conversion shares is capped at 19.99% of outstanding common stock unless shareholder approval is obtained.

• · Series B Preferred Stock ranks senior to all Junior Securities (common stock and equivalents) but junior to Series A Preferred Stock.
• · Holders have no voting rights except as required by law.
• · Conversion price is fixed at $1.25 per share, subject to adjustment.
• · The Corporation must reserve sufficient authorized but unissued common shares for conversion and dividend payments.
• · No fractional shares will be issued upon conversion; cash adjustment or rounding up applies.
• · The Certificate of Designation references a Cooperation Agreement dated March 6, 2026 among Nuvve, Oelion AB, and OMNIA Group Holdings AG.

25-06-2026

TerrAscend Corp. closed an oversubscribed $21.7 million convertible debenture financing, using $11.1 million to retire higher-interest debt and the remainder for M&A. The new debentures mature in 2031 at 8.00% interest, reducing the company's blended interest cost and extending its maturity profile. However, the financing involved insider participation by Edward J. Schutter (1,000 debentures for $1 million), constituting a related party transaction, and the company continues to face significant U.S. federal legal risks despite recent rescheduling of certain marijuana products.

• · The debentures mature on September 30, 2031.
• · Conversion price is US$0.87 per common share.
• · The debentures are secured by a second lien on the U.S. business.
• · The company relied on exemptions from formal valuation and minority shareholder approval under MI 61-101 for the insider participation.
• · The U.S. Department of Justice issued a final rule on April 23, 2026, rescheduling marijuana in FDA-approved drugs and state medical marijuana from Schedule I to Schedule III, but other marijuana remains Schedule I.

25-06-2026

Ligand Pharmaceuticals priced a $625 million (upsized from an undisclosed initial amount) 0.00% convertible senior notes offering due 2031, with an additional $75 million option for initial purchasers. Net proceeds are estimated at $605.3 million (or $678.2 million if the option is fully exercised), with $72.9 million allocated to convertible note hedge transactions and $60 million to repurchase 228,859 shares at $262.17 per share. The remaining proceeds will be used for general corporate purposes, including the previously announced acquisition of XOMA Royalty Corporation. The notes carry a conversion price of $334.27 per share (a 27.5% premium over the closing price of $262.17 on June 22, 2026), and the warrants have a strike price of $524.34 per share (a 100% premium).

• · The notes are 0.00% interest, unsecured senior obligations, maturing September 15, 2031.
• · Ligand may not redeem the notes before September 21, 2029; after that, redemption is allowed if stock price is at least 130% of conversion price for 20 trading days in a 30-day period.
• · Holders can convert notes only upon certain circumstances before June 15, 2031; after that, conversion is freely allowed until maturity.
• · Upon conversion, Ligand will pay cash up to the principal amount and may settle any excess in cash, shares, or a combination.
• · The convertible note hedge transactions are intended to reduce dilution upon conversion, but the warrant transactions could cause dilution if the stock price exceeds $524.34.
• · Option counterparties may engage in derivative transactions that could affect the stock price and conversion value.
• · The offering is a private placement under Rule 144A to qualified institutional buyers.
• · Ligand has no present commitments for the remaining proceeds beyond the XOMA Royalty Corporation acquisition.

25-06-2026

Blue Owl Real Estate Net Lease Trust reported a strong performance for Q3 FY 2025 with revenue growing 15% YoY to $5 billion, driven by a 12% increase in AUM to $50 billion and a 14% increase in net investment income to $1.2 billion. However, net realized gains declined significantly by 87.5% YoY to $50 million, and the industrial segment saw a 2.7% decrease in NOI to $500 million.

• · Net realized gains declined 87.5% YoY to $50 million in Q3 FY 2025.
• · Industrial segment NOI decreased 2.7% YoY to $500 million.
• · Office segment NOI increased 5% YoY to $200 million.

25-06-2026

ON Semiconductor (onsemi) has agreed to acquire Synaptics in an all-stock transaction valued at approximately $7 billion enterprise value, with a fixed exchange ratio of 1.350 onsemi shares per Synaptics share, representing an ~19% premium to the 10-day VWAP. The deal aims to position onsemi at the intersection of Power, Sense, Connected Compute, and Control for Physical AI, expanding its TAM by $30 billion to $243 billion by 2030. However, the transaction is not expected to close until mid-2027, subject to regulatory and stockholder approvals, and carries integration risks.

• · The transaction is expected to be accretive to non-GAAP EPS within 18 months of closing.
• · onsemi reiterates its financial outlook for Q2 fiscal 2026 (provided May 4, 2026); Synaptics reiterates its Q4 fiscal 2026 outlook (provided May 7, 2026).
• · The Boards of Directors of both companies have unanimously approved the transaction.
• · The transaction is subject to Synaptics stockholder approval, regulatory approvals, and other customary conditions.
• · onsemi remains committed to its existing capital return policy during the pendency period.
• · A conference call for the financial community is scheduled for 5:00 p.m. EDT on June 25, 2026.

25-06-2026

INVO Fertility, Inc. acquired 100% of the membership interests of HRCFG, LLC, the operator of its Alabama joint venture fertility clinic, for a total purchase price of $175,001. The acquisition will allow the company to consolidate the Alabama clinic's accounts into its financial statements. Additionally, INVO resolved Nasdaq listing non-compliance by filing its overdue 10-K and 10-Q reports.

• · The company regained compliance with Nasdaq timely filing rules on June 23, 2026, after filing its 10-Q on June 22, 2026.
• · The Alabama JV clinic operates under the name 'Innovative Fertility Specialists'.
• · Sellers transferred all Business Properties including intellectual property rights to HRCFG.

25-06-2026

Enova International, Inc. amended its ODR 2022 Securitization Facility on June 25, 2026, increasing total commitment to $420M with Class A ($338M) and Class B ($82M) revolving loans. The facility extends the revolving period to June 2028 and maturity to June 2029, with borrowing rates of CP+2.35% (Class A) and SOFR+7.50% (Class B).

• · Amendment No. 5 to Credit Agreement and Reaffirmation of Performance Guaranty was entered into on June 25, 2026.
• · The facility is a revolving receivables facility with Class A and Class B tranches.
• · Revolving Period End Date is June 2028, Maturity Date is June 2029.
• · The Company acts as performance guarantor.

25-06-2026

Aether Holdings, Inc. (ATHR) entered into an At The Market Offering Agreement with Rodman & Renshaw LLC on June 25, 2026, allowing the company to sell up to $10,998,532 of its common stock through an at-the-market offering. The company will pay a commission of up to 3.0% of gross proceeds and has no obligation to sell any shares. The offering is registered under an S-3 shelf registration (File No. 333-296182) that was declared effective on June 2, 2026.

• · The Sales Agreement was filed as Exhibit 1.1 to the 8-K; Venable LLP opined on the validity of the shares (Exhibit 5.1).
• · The Registration Statement on Form S-3 (File No. 333-296182) was originally filed on May 22, 2026 and declared effective on June 2, 2026.
• · Company may also sell shares in privately negotiated transactions or block transactions with consent.
• · No obligation to sell any shares; the Company may suspend offers at any time.
• · Contains customary representations, warranties, indemnification obligations, and expense reimbursement for the Sales Agent.

25-06-2026

Sculptor Diversified Real Estate Income Trust, Inc. renewed its advisory agreement with Sculptor Advisors LLC through June 21, 2027, on substantially the same terms as the prior agreement. At the 2026 Annual Meeting, all seven director nominees were elected, with Anthony Boni receiving 14,255,751 votes for and 7,270,730 against, while the other six nominees received unanimous support. The meeting had a quorum of 21,526,481 shares (40.34% of total shares entitled to vote).

• · The Advisory Agreement was renewed on substantially the same terms as the prior Sixth Amended and Restated Advisory Agreement (dated August 11, 2025, as amended January 13, 2026).
• · The new agreement is effective June 21, 2026 and runs through June 21, 2027.
• · Anthony Boni received 7,270,730 votes against his election, representing approximately 33.8% of the votes cast, while the other six nominees received unanimous support with no votes against or abstentions.
• · No broker non-votes were reported for any director election.

25-06-2026

SharonAI Holdings, Inc. raised approximately $1.6 billion in aggregate gross proceeds through a combined equity and convertible note offering. The equity offering of approximately 6,719,896 shares and pre-funded warrants for up to 6,374,823 shares generated $900 million, while the $700 million 4.75% Convertible Senior Notes due 2032 were issued with a conversion price of approximately $99.66 per share, representing a 45% premium over the Nasdaq Minimum Price. The transactions closed on June 23, 2026, and June 22, 2026, respectively, with the notes settlement occurring through June 26, 2026.

• · The Notes are senior, unsecured obligations maturing on June 15, 2032, with interest payable quarterly on January 1, April 1, July 1, and October 1.
• · The Company may force convert the Notes after 18 months from issuance if certain VWAP and volume conditions are met (Daily VWAP > 200% of conversion price for 20 of 30 trading days, daily dollar volume ≥ $50 million for 20 of 30 trading days).
• · Holders may require repurchase at 100% of principal plus accrued interest upon a Fundamental Change.
• · The Notes are fully and unconditionally guaranteed on a senior unsecured basis by the Subsidiary Guarantors.
• · Events of default include payment defaults (30-day cure for interest), conversion failures, covenant breaches (60-day cure), cross-default on ≥ $7.5 million indebtedness, bankruptcy, and final judgments ≥ $7.5 million.
• · The equity offering closed on June 23, 2026; the notes settlement occurred via delivery versus payment from June 22 to June 26, 2026.

25-06-2026

Heron Therapeutics received a Nasdaq deficiency notice on June 25, 2026, because its common stock closing bid price remained below $1.00 per share for 30 consecutive trading days (May 12 to June 24, 2026). The company has an initial 180-day cure period until December 22, 2026, to regain compliance, and may be eligible for an additional 180-day period if certain conditions are met. While the notice does not immediately affect trading, failure to cure could lead to delisting, and the company is exploring options including a potential reverse stock split.

• · The deficiency period ran from May 12, 2026 to June 24, 2026.
• · The initial cure deadline is December 22, 2026.
• · To regain compliance, the closing bid price must be at least $1.00 for a minimum of ten consecutive days.
• · If not cured in the initial period, the company may be eligible for an additional 180-day period if it meets other listing standards and provides notice of intent to cure, possibly via a reverse stock split.
• · If delisting is initiated, the company may appeal to a Nasdaq Hearings Panel.
• · The company's common stock continues to trade under the symbol 'HRTX' on The Nasdaq Capital Market.

25-06-2026

Alset Inc. (AEI) entered into a securities purchase agreement with DSS Inc. on June 23, 2026, loaning $1,000,000 in exchange for a convertible promissory note bearing 3% simple interest and warrants to purchase 17,777,776 shares of DSS common stock at $0.50 per share. The transaction is a related-party deal as both companies share common control under Chairman and CEO Chan Heng Fai, and several Alset directors also serve on DSS's board. The conversion and warrant exercise are subject to DSS stockholder approval.

• · The note is payable upon demand and matures in five years.
• · Conversion price of the note is $0.45 per share of DSS common stock.
• · Warrant exercise price is $0.50 per share, and warrants expire on the third anniversary.
• · Chan Heng Fai and Chan Tung Moe recused themselves from board deliberation and voting on the transaction.
• · The transaction was approved by Alset's Board of Directors and Audit Committee.

25-06-2026

onsemi (ON) has agreed to acquire Synaptics (SYNA) in an all-stock transaction valued at approximately $7 billion enterprise value, with a fixed exchange ratio of 1.350 ON shares per SYNA share, representing an ~19% premium to the 10-day VWAP. The combined company aims to lead in Physical AI by integrating Synaptics' Edge AI compute and connectivity with onsemi's power and sensing portfolio, expanding onsemi's TAM by $30B to $243B by 2030. However, the transaction is not expected to close until mid-2027, subject to regulatory and stockholder approvals, and carries integration risks.

• · Transaction is expected to be accretive to non-GAAP EPS within 18 months of closing.
• · onsemi reiterates its financial outlook for Q2 fiscal 2026 (provided May 4, 2026).
• · Synaptics reiterates its financial outlook for Q4 fiscal 2026 (provided May 7, 2026).
• · One Synaptics board member is expected to join onsemi's board.
• · Closing expected mid-2027, subject to Synaptics stockholder approval and regulatory approvals.
• · onsemi intends to maintain its existing capital return policy during the pendency period.
• · Morgan Stanley is lead financial advisor to onsemi; Qatalyst Partners is exclusive financial advisor to Synaptics.

25-06-2026

Ulixe Corp. (ULIX) completed the sale of its wholly owned subsidiary Ulixe Nova S.r.l. to Condotti Capital S.r.l. for nominal consideration of €1.00, as part of a strategic reorganization ahead of its planned Nasdaq uplisting. The disposal eliminates future funding obligations and administrative burdens associated with Ulixe Nova, which had liquidity constraints and anticipated recapitalization needs. The company's remaining structure includes Ulixe Italy, Dale Consulting, Ulixe Pharma, MBSNet, and Fintexa, with MBSNet being a fintech and digital payments provider acquired in November 2025.

• · The sale was completed on June 18, 2026, and the 8-K was filed on June 25, 2026.
• · The parties agreed to reconcile outstanding reciprocal payables and receivables subject to a 90-day post-closing adjustment period.
• · Prior to the Transfer Agreement, a non-binding letter of intent was executed with provisions for settlement of accounts between Ulixe Nova and Dale Consulting S.r.l.
• · The Board considered Ulixe Nova's historical and anticipated contribution, operational and financial performance, and future capital requirements in approving the disposal.
• · MBSNet S.r.l., acquired on November 17, 2025, owns 100% of Fintexa S.r.l. and includes the MBSNet, Fintexa, and MBSPay brands.

25-06-2026

Robinhood Markets closed a $2.2 billion offering of 0.00% convertible senior notes due 2029, raising net proceeds of approximately $2.169 billion. The company used $290 million to repurchase 2.743 million shares of Class A common stock and $123.2 million to acquire capped calls that cap dilution at a conversion price of $174.42 per share. CFO Shiv Verma highlighted the transaction as enhancing strategic flexibility for future growth, though the offering introduces potential dilution risk if the stock price rises significantly.

• · The offering includes a full exercise of a $200 million option to purchase additional notes by initial purchasers.
• · Capped calls cap dilution at an initial cap price of approximately $237.85 per share, a 125% premium to the June 22, 2026 closing price.
• · Factoring in the share repurchase, Robinhood anticipates no net dilution until the share price exceeds $303.95.
• · Remaining net proceeds will be used for general corporate purposes, including organic growth investments, potential acquisitions, and/or capital expenditures.
• · Robinhood may repurchase additional shares under its stock repurchase program following the offering.

25-06-2026

PetVivo Holdings announced a definitive agreement to acquire PiezoBioMembrane (PBM), a developer of advanced functional biomaterials and piezoelectric technologies, for 3,000,000 shares of PetVivo common stock subject to milestone-based retention provisions. The acquisition is expected to strengthen PetVivo's IP portfolio and create opportunities across animal and human health markets, with PBM becoming a subsidiary of Cosmeta Corp. The transaction remains subject to customary closing conditions and no revenue or earnings impact has been disclosed.

• · PBM will become a wholly owned subsidiary of Cosmeta Corp, PetVivo's wholly owned operating subsidiary.
• · The consideration includes milestone-based retention and forfeiture provisions.
• · Closing is subject to customary conditions including completion of due diligence, financing, and execution of related documents.
• · PetVivo holds a portfolio of 12 patents and 6 trade secrets.
• · Lead products SPRYNG and PrecisePRP are currently commercially available.

25-06-2026

ASP Isotopes Inc. (ASPI) filed an 8-K on June 25, 2026, reporting the adoption of an amended and restated certificate of incorporation that renames the company to Noble Africa Inc. and establishes a dual-class common stock structure (Class A with 1 vote per share, Class B with 10 votes per share). The filing also authorizes 1.25 billion total shares, including 1 billion Class A shares, 200 million Class B shares, and 50 million preferred shares. No financial performance data is provided in this filing.

• · The company changed its name from ENDRA Life Sciences Inc. to Noble Africa Inc.
• · Class B common stock carries 10 votes per share, while Class A carries 1 vote per share.
• · Class B shares automatically convert to Class A upon transfer (except permitted transfers) or by majority vote of Class B holders.
• · The registered agent is Corporation Service Company at 251 Little Falls Drive, Wilmington, DE 19808.

25-06-2026

Americas CarMart entered into a First Amendment and Limited Waiver to its Credit Agreement with lenders led by Silver Point Finance, waiving anticipated defaults on liquidity, collateral coverage, and reporting covenants through a Specified Period ending as early as September 7, 2026. The company agreed to pay up to $18.0 million in fees, must maintain minimum liquidity of $7 million weekly and $5 million otherwise, and meet milestones including a marketing process and support agreement. Separately, CFO Jonathan Collins resigned effective July 31, 2026, replaced by Marie Persichetti, while directors Julia Davis resigned and Gilbert Nathan and Michael Wartell were appointed as independent directors.

• · The Specified Period terminates on the earliest of: Scheduled Termination Date (September 7, 2026, extendable to September 21 or November 6, 2026), occurrence of any non-Specified Default, breach of Amendment conditions, or failure to meet milestones.
• · If all milestones are met and covenants complied with by the Scheduled Termination Date, the limited waiver converts into a permanent waiver of the Specified Defaults.
• · Minimum Collateral Coverage Ratio: 1.25 to 1.00 as of June 30, 2026, or 1.20 to 1.00 as of the last day of any calendar month thereafter.
• · New directors Nathan and Wartell each receive $45,000 per month for a minimum of three months, plus $4,000 per day for commitments exceeding four hours.
• · Marie Persichetti's total cash retention awards now amount to $515,000 ($315,000 previously + $200,000 additional).
• · Vickie D. Judy received an additional $200,000 cash retention bonus.
• · Julia Davis resigned effective June 23, 2026, with no disagreement with the company.

25-06-2026

Vivos Therapeutics extended its strategic financing agreement with Streeterville Capital to August 31, 2026, reaffirming Streeterville's commitment to convert up to $4.5 million of debt into a mix of perpetual preferred stock and common shares. The extension follows the company's determination that the original June 15 timeframe was too short to complete an equity raise; Vivos must first raise $2.6 million to trigger the conversion. While the agreement supports efforts to strengthen stockholders' equity and maintain Nasdaq compliance, risks of failing to raise sufficient capital on time remain.

• · The original agreement committed Streeterville to convert debt into equity on a dollar-for-dollar basis with equity raised by the Company.
• · The extended timeframe permits the previously announced rights offering to commence.
• · Vivos maintains that the company has successfully pivoted to its new strategic business model and is performing well on the new strategy.
• · OSA affects nearly 1 billion adults aged 30-69 worldwide, with 80% or more remaining undiagnosed.
• · The filing includes cautionary language that failing to raise the required new equity timely or in sufficient amounts would cause the debt-to-equity exchange to become null and void.

25-06-2026

VisionWave Holdings, Inc. completed the Stage 2 and Stage 3 closings under its Exchange Agreement with SaverOne 2014 Ltd., receiving SaverOne ordinary shares in exchange for issuing 1,331,637 shares of its common stock valued at approximately $4.26 million. Simultaneously, VisionWave assigned rights to 14.84 billion SaverOne shares to Adrian Holdings S.R.L. to partially satisfy a $10 million promissory note, reducing the note by about $1.43 million (110% of assigned share value). After these transactions, VisionWave beneficially owns approximately 41% of SaverOne but does not control it and will not consolidate it in financial statements.

• · The Stage 2 and Stage 3 closings occurred on June 22, 2026, following achievement and certification of Milestone 1 and Milestone 2.
• · VisionWave shares were issued in reliance on Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D, as restricted securities.
• · No underwriters were involved and no underwriting discounts or commissions were paid.
• · The Assignment Agreement does not reduce, increase, or modify the aggregate number of SaverOne ordinary shares issuable under the Exchange Agreement.
• · VisionWave intends to account for its investment in SaverOne under the equity method of accounting and will not consolidate SaverOne.
• · The VWAV Average Price was used to determine the number of shares issued; $100,000 based on $5.34 VWAP was set aside pending SaverOne providing management names.

25-06-2026

Capri Holdings Ltd, through its subsidiary Michael Kors (USA), Inc., entered into Amendment No. 1 to its Amended and Restated Credit Agreement on June 24, 2026, replacing existing revolving commitments and loans with new 2026 Revolving Commitments and Revolving Loans. The amendment, effective upon satisfaction of conditions including legal opinions and no default, involves a syndicate of lenders led by JPMorgan Chase and Barclays. No specific financial amounts or performance metrics are disclosed in this filing.

• · The amendment replaces existing revolving commitments and loans with new 2026 Revolving Commitments and Revolving Loans.
• · Conditions for effectiveness include receipt of legal opinions from multiple law firms, a solvency certificate from the CFO, and no Event of Default.
• · The amendment was executed on June 24, 2026, and filed on June 25, 2026.

25-06-2026

Pitney Bowes redeemed all $347M of its 6.875% Senior Notes due March 2027, eliminating its nearest-term debt maturity and pushing the next scheduled maturity to March 2029. The company also upsized its Term Loan A by $150M to a total outstanding balance of $302M, with no changes to terms or the May 2031 maturity date. The redemption was funded by the Term Loan A upsizing proceeds and existing cash, and the company highlighted lower interest expense, reduced leverage, and the involvement of new lenders as signs of an improved credit profile.

• · The redemption closed on June 24, 2026.
• · The Term Loan A upsizing closed on June 23, 2026.
• · The next scheduled debt maturity is March 2029.
• · The Term Loan A maturity date remains May 18, 2031.
• · New lenders beyond historical relationship banks participated in the upsizing.

25-06-2026

Triller Group Inc. (Nasdaq: ILLR) announced a definitive agreement to acquire a significant economic exposure position in SpaceX (Nasdaq: SPCX) through a secured financing arrangement, to be held as a strategic treasury asset on its balance sheet. The position was established before SpaceX’s public listing and is being acquired at a meaningful discount to current market value, but no dollar amounts or specific economic terms were disclosed. The transaction is expected to close in the coming days and positions Triller as one of the only Nasdaq-listed companies with disclosed balance-sheet SpaceX exposure.

• · Transaction financed through a secured financing arrangement with the underlying position serving as collateral
• · Company retains a portion of the position as treasury for shareholder benefit
• · Wing-Fai Ng stated the transaction 'fundamentally changes how investors should look at Triller'
• · Transaction expected to close in the coming days subject to customary conditions
• · No financial terms (e.g., purchase price, size of position, discount percentage) were disclosed in the press release

25-06-2026

Agassi Sports Entertainment Corp. (AASP) entered into a Name and Likeness License Agreement with AKA Licenses, LLC, securing a non-exclusive worldwide license to use Andre Agassi's name, likeness, and related intellectual property for its racket sports media and entertainment business. The agreement formalizes a previously verbal arrangement and includes a one-time fee of $250,000 payable upon AASP raising over $3,000,000 or within six months, with no ongoing royalty fees. While the license secures key branding rights, it is non-exclusive (except for the corporate name), requires pre-approval for new uses, and does not cover third-party media content, limiting AASP's operational flexibility.

• · The license is non-exclusive except for AASP's corporate name 'Agassi Sports Entertainment Corp.' which is exclusive during the term.
• · AASP must obtain prior written approval from AKA Licenses for all new materials using the Licensed IP, though existing materials as of the Effective Date are deemed approved.
• · AASP cannot sub-license the Name or Likeness without prior written approval from AKA Licenses.
• · The license does not extend to photographs, videos, or other media where AKA Licenses does not hold copyright; AASP is solely responsible for obtaining those licenses.
• · AKA Licenses represents that Agassi will be bound by the agreement and will execute an Inducement Letter.
• · No royalty fees are due; the only consideration is the one-time $250,000 fee.
• · AASP is not obligated to actually use the Name or Likeness in its business.
• · The agreement is governed by Nevada law and contains standard representations and warranties from both parties.

25-06-2026

Milestone Scientific Inc. (MLSS) announced strategic governance changes to support its next phase of growth, including the transition of Benedetta I. Casamento from Chair to Executive Chair and the appointment of two new independent directors, Greg Shilling and Kelly Ann Ulto. The company also entered into a restructured agreement with founder Leonard Osser to align shareholder interests and provide greater operational flexibility. These changes aim to strengthen board expertise in healthcare technology, finance, and governance, but no financial metrics or performance data were disclosed in the filing.

• · Greg Shilling has over 30 years of leadership experience in healthcare technology, software, AI, and cybersecurity.
• · Kelly Ann Ulto is a CPA with over 30 years of experience in audit, financial reporting, and internal controls, and has taught at Fordham University since 2004.
• · The restructured agreement with founder Leonard Osser provides the company with greater flexibility moving forward.
• · No financial results, revenue figures, or performance metrics were disclosed in this filing.

25-06-2026

SUI Group Holdings Ltd. (SUIG) expanded its strategic lending partnership with Bluefin, agreeing to lend an additional 4 million SUI (total 6 million SUI) and increasing its revenue share from 5.00% to 11.00%, payable in SUI. The additional capital will support Bluefin's participation in financing Bluewater's acquisition of Suilend, the largest DeFi lending platform on Sui. The amended agreement retains a three-year term through September 2028.

• · The amended agreement retains the original three-year term running through September 2028 and may be extended by mutual consent.
• · SUIG's revenue share is expected to provide an enhanced return relative to native staking.
• · SUI Group is the only publicly traded company with an official Sui Foundation relationship.
• · The company plans to continue its specialty finance operations while executing its SUI treasury strategy.